99%+ Purity Rimonabant (Acomplia) CAS No.: 168273-06-1

Product Details:

 

Rimonabant Powder Information
Rimonabant Price100gAccording to your needs
500gAccording to your needs
1000gAccording to your needs
Packagingdiscreet packages
Delivery timeAbout 7 days
ShippingEMS, Hongkong Post, DHL, TNT, Fedex and so on.
Payment termsWU, MG, Bitcoin, T/T
Minimum order

10g powder

Inquiry

99%+ Purity Rimonabant (Acomplia) CAS No.: 168273-06-1

 

Name: Rimonabant
CAS: 168273-06-1
Molecular formula: C22H21Cl3N4O.
Molecular weight: 500.25
Formulation: White or almost white crystalline powder
Purity: ≥ 99% by HPLC
Appearance White crystalline powder

 

Rimonabant Specifications:

COA

Test ItemsSpecificationTest Results
DescriptionWhite crystalline powderWhite crystalline powder
IdentificationIR , UV conformConform
Loss on drying≤0.5ml0.21ml
Residue on ignitionNot more than 0.2%0.06ml
IronNot more than 0.005%0.0018%
Heavy metalsNot more than 0.001%0.0006%
Related substancesTotal: Not more than 1.0%
Individual: Not more than 0.5%
0.32%
0.14%
E-isomerNot more than 0.3%0.19%
Organic volatile impuritiesConformsConforms
Assay99.0~101.0%99.51%
ConclusionConform with USP30

 

Rimonabant Description:

Rimonabant is a weight loss drug, can significantly reduce weight, reduce waist circumference and reduce risk factors for cardiovascular disease, but also can improve blood lipids and insulin resistance and metabolic syndrome, especially for the presence of clinical obesity or heart disease people at risk.

An experimental wonder drug, Rimonabant, helps you lose weight, quit smoking and it also helps protect your heart. Trials have shown that 33% of people on Rimonabant lost 10% of body weight and kept their weight down for two years - this is a record, no other diet drug has managed to keep a person's weight down for so long.

The second 33% lost 5% of body weight and kept it down. As well as keeping you lean, the drug also helps you quit the smoking habit. This will be of great interest for many smokers who are afraid to give up because they say they will put on loads of weight if they do.

 

Rimonabant Application:

Rimonabant is said to have reduced the overall body fat by 10% in one out of three users. Also, it is reported that those users did not gain back more than a kilo over the next two years if the patients remained on Rimonabant. Rimonabant was recommended for those with a BMI of 30 or greater, who were considered obese, and is most successful when combined with exercise and a proper diet. It was not recommended for those who just wanted to lose a few pounds. Sanofi-Aventis is conducting studies to determine if Rimonabant is valuable in smoking cessation therapy, and initial results are positive.

 

Obesity

In a 2006 (2 year) study reported in JAMA, "Compared with the placebo group, the 20 mg of rimonabant group produced greater mean (SEM) reductions in weight (-6.3 [0.2] kg vs -1.6 [0.2] kg; P<.001), waist circumference (-6.1 [0.2] cm vs -2.5 [0.3] cm; P<.001), and level of triglycerides (percentage change, -5.3 [1.2] vs 7.9 [2.0]; P<.001) and a greater increase in level of high-density lipoprotein cholesterol (percentage change, 12.6 [0.5] vs 5.4 [0.7]; P<.001)."

 

Smoking cessation

Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with Rimonabant and Tobacco Use (STRATUS) program involves more than 6,000 subjects.

STRATUS is designed to explore two smoking-related therapies: first, to use rimonabant directly to aid in smoking cessation; second, to help prevent weight gain in former smokers. Initial results apparently suggest rimonabant is effective for both uses. However, the FDA has explicitly stated to Sanofi that, without additional studies, rimonabant cannot be approved in the United States for smoking cessation therapy.

Please send your inquiry with DESTINATION,PRODUCT NAMES and QUANTITIES directly to us


Send